CIK 0000879169
- Large accelerated filer
INCYTE CORP
Sign in to watch- Ticker
- INCY
- Exchange
- Nasdaq
- Industry
- Services-Commercial Physical & Biological Research
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 943136539
- Phone
- +1 302-498-6700
- Business address
- 1801 AUGUSTINE CUT-OFF, WILMINGTON, DE, 19803
- Former names
- INCYTE INC, INCYTE GENOMICS INC, INCYTE PHARMACEUTICALS INC
- 4 Grant or award Director acquired 984 shares (grant or award)
- 4 Grant or award Director acquired 361 shares (grant or award)
- 4 Grant or award Director acquired 367 shares (grant or award)
- 4 Grant or award EVP, Head of US Oncology acquired 27,812 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 36,101 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Special Advisor to the CEO acquired 6,016 shares (grant or award)
- 4 Grant or award Director acquired 2,518 shares (grant or award)
- 4 Grant or award Director acquired 2,518 shares (grant or award)
- 4 Grant or award Director acquired 2,518 shares (grant or award)
- 4 Grant or award Director acquired 2,518 shares (grant or award)
- 4 Grant or award Director acquired 5,036 shares (grant or award)
- 4 Grant or award Director acquired 2,518 shares (grant or award)
- 4 Shares withheld for taxes Director gave up 849 shares (to pay taxes)
- 4 Grant or award Director acquired 2,518 shares (grant or award)
- 4 Planned sale EVP & General Counsel sold 1,795 shares at $68.00 ($122,060)
- 4 Planned sale Principal Accounting Officer sold 1,614 shares at an average $65.38 ($105,516)
- 4 Grant or award EVP & General Manager US acquired 26,135 shares (grant or award)
- 4 Grant or award EVP, GMAPPS acquired 22,141 shares (grant or award)
Page 8 of 82 · 1,628 filings